| 4A28: reference: The Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate SB743921 by an Allosteric Resistance Mechanism., Talapatra SK, Anthony NG, Mackay SP, Kozielski F, J Med Chem. 2013 Jul 22. PMID: 23875972 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).